We are pleased to announce that Haodi Wu, PhD, will join the VMI with a primary appointment in HVI-Cardiology as an Assistant Professor in the tenure stream on October 1, 2020. Dr. Wu earned his BS from China Agriculture University and a PhD in Physiology from Peking...

Addressing unproven theories spanning for more than a decade, we demonstrate that specific pieces of genetic material called microRNAs are transported from the blood into the lining of blood vessels of the lung to promote a deadly disease called pulmonary...

The Chan Lab's work on BOLA3 and pulmonary hypertension was selected as a 2019 top research advance by the AHA in heart disease and stroke! Read on the AHA website: Top heart disease and stroke research advances in 2019: The American Heart Association identifies the...

Drs. Mark Gladwin and Jesus Tejero's R01 titled, “Antidote for inhaled CO poisoning based on mutationally engineered neuroglobin,” was competitively renewed with annual direct costs of $637,860 by the National Institutes of Health/National Heart, Lung, and Blood...